A citation-based method for searching scientific literature


List of co-cited articles
18 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.
Sue Richards, Nazneen Aziz, Sherri Bale, David Bick, Soma Das, Julie Gastier-Foster, Wayne W Grody, Madhuri Hegde, Elaine Lyon, Elaine Spector,[...]. Genet Med 2015
50

The impact of communicating uncertain test results in cancer genetic counseling: A systematic mixed studies review.
Niki M Medendorp, Pomme E A van Maarschalkerweerd, Laxsini Murugesu, Joost G Daams, Ellen M A Smets, Marij A Hillen. Patient Educ Couns 2020
6
50

Patients' Medical and Psychosocial Experiences After Detection of a CDH1 Variant With Multigene Panel Testing.
Jada G Hamilton, Jessica M Long, Amanda C Brandt, Jamie Brower, Heather Symecko, Erin E Salo-Mullen, Stephanie N Christian, Tricia Harstad, Fergus J Couch, Judy E Garber,[...]. JCO Precis Oncol 2019
10
25


Next-Generation Testing for Cancer Risk: Perceptions, Experiences, and Needs Among Early Adopters in Community Healthcare Settings.
Kathleen R Blazer, Bita Nehoray, Ilana Solomon, Mariana Niell-Swiller, Julie O Culver, Gwen C Uman, Jeffrey N Weitzel. Genet Test Mol Biomarkers 2015
35
25

Evaluation of a Streamlined Oncologist-Led BRCA Mutation Testing and Counseling Model for Patients With Ovarian Cancer.
Nicoletta Colombo, Gloria Huang, Giovanni Scambia, Eva Chalas, Sandro Pignata, James Fiorica, Linda Van Le, Sharad Ghamande, Santiago González-Santiago, Isabel Bover,[...]. J Clin Oncol 2018
50
25

Guidelines for diagnostic next-generation sequencing.
Gert Matthijs, Erika Souche, Mariëlle Alders, Anniek Corveleyn, Sebastian Eck, Ilse Feenstra, Valérie Race, Erik Sistermans, Marc Sturm, Marjan Weiss,[...]. Eur J Hum Genet 2016
235
25

Advantages and Perils of Clinical Whole-Exome and Whole-Genome Sequencing in Cardiomyopathy.
Francesco Mazzarotto, Iacopo Olivotto, Roddy Walsh. Cardiovasc Drugs Ther 2020
11
25

Recommendations for returning genomic incidental findings? We need to talk!
Wylie Burke, Armand H Matheny Antommaria, Robin Bennett, Jeffrey Botkin, Ellen Wright Clayton, Gail E Henderson, Ingrid A Holm, Gail P Jarvik, Muin J Khoury, Bartha Maria Knoppers,[...]. Genet Med 2013
213
25

A prospective evaluation of whole-exome sequencing as a first-tier molecular test in infants with suspected monogenic disorders.
Zornitza Stark, Tiong Y Tan, Belinda Chong, Gemma R Brett, Patrick Yap, Maie Walsh, Alison Yeung, Heidi Peters, Dylan Mordaunt, Shannon Cowie,[...]. Genet Med 2016
203
25

Lessons Learned from Large-Scale, First-Tier Clinical Exome Sequencing in a Highly Consanguineous Population.
Dorota Monies, Mohammed Abouelhoda, Mirna Assoum, Nabil Moghrabi, Rafiullah Rafiullah, Naif Almontashiri, Mohammed Alowain, Hamad Alzaidan, Moeen Alsayed, Shazia Subhani,[...]. Am J Hum Genet 2019
81
25

Meta-analysis of the diagnostic and clinical utility of genome and exome sequencing and chromosomal microarray in children with suspected genetic diseases.
Michelle M Clark, Zornitza Stark, Lauge Farnaes, Tiong Y Tan, Susan M White, David Dimmock, Stephen F Kingsmore. NPJ Genom Med 2018
174
25

Prevalence of Variant Reclassification Following Hereditary Cancer Genetic Testing.
Jacqueline Mersch, Nichole Brown, Sara Pirzadeh-Miller, Erin Mundt, Hannah C Cox, Krystal Brown, Melissa Aston, Lisa Esterling, Susan Manley, Theodora Ross. JAMA 2018
88
25

The counsellees' view of an unclassified variant in BRCA1/2: recall, interpretation, and impact on life.
Joël Vos, Wilma Otten, Christi van Asperen, Anna Jansen, Fred Menko, Aad Tibben. Psychooncology 2008
82
25


Multicenter Prospective Cohort Study of the Diagnostic Yield and Patient Experience of Multiplex Gene Panel Testing For Hereditary Cancer Risk.
Gregory E Idos, Allison W Kurian, Charité Ricker, Duveen Sturgeon, Julie O Culver, Kerry E Kingham, Rachel Koff, Nicolette M Chun, Courtney Rowe-Teeter, Alexandra P Lebensohn,[...]. JCO Precis Oncol 2019
2
100

Lynch Syndrome Limbo: Patient Understanding of Variants of Uncertain Significance.
Ilana Solomon, Elizabeth Harrington, Gillian Hooker, Lori Erby, Jennifer Axilbund, Heather Hampel, Kara Semotiuk, Amie Blanco, William M P Klein, Francis Giardiello,[...]. J Genet Couns 2017
30
25

Uncertainty related to multigene panel testing for cancer: a qualitative study on counsellors' and counselees' views.
Niki M Medendorp, Marij A Hillen, Laxsini Murugesu, Cora M Aalfs, Anne M Stiggelbout, Ellen M A Smets. J Community Genet 2019
12
25

Developing a conceptual, reproducible, rubric-based approach to consent and result disclosure for genetic testing by clinicians with minimal genetics background.
Kelly E Ormond, Miranda L G Hallquist, Adam H Buchanan, Danielle Dondanville, Mildred K Cho, Maureen Smith, Myra Roche, Kyle B Brothers, Curtis R Coughlin, Laura Hercher,[...]. Genet Med 2019
24
12

HOXB13 is a susceptibility gene for prostate cancer: results from the International Consortium for Prostate Cancer Genetics (ICPCG).
Jianfeng Xu, Ethan M Lange, Lingyi Lu, Siqun L Zheng, Zhong Wang, Stephen N Thibodeau, Lisa A Cannon-Albright, Craig C Teerlink, Nicola J Camp, Anna M Johnson,[...]. Hum Genet 2013
124
12

Breast-cancer risk in families with mutations in PALB2.
Antonis C Antoniou, Silvia Casadei, Tuomas Heikkinen, Daniel Barrowdale, Katri Pylkäs, Jonathan Roberts, Andrew Lee, Deepak Subramanian, Kim De Leeneer, Florentia Fostira,[...]. N Engl J Med 2014
481
12

CHEK2 variant I157T may be associated with increased breast cancer risk.
Outi Kilpivaara, Pia Vahteristo, Jacob Falck, Kirsi Syrjäkoski, Hannaleena Eerola, Douglas Easton, Jirina Bartkova, Jiri Lukas, Päivi Heikkilä, Kristiina Aittomäki,[...]. Int J Cancer 2004
110
12

Evaluation of Polygenic Risk Scores for Breast and Ovarian Cancer Risk Prediction in BRCA1 and BRCA2 Mutation Carriers.
Karoline B Kuchenbaecker, Lesley McGuffog, Daniel Barrowdale, Andrew Lee, Penny Soucy, Joe Dennis, Susan M Domchek, Mark Robson, Amanda B Spurdle, Susan J Ramus,[...]. J Natl Cancer Inst 2017
121
12

Germline and Somatic Mutations in Prostate Cancer for the Clinician.
Heather H Cheng, Alexandra O Sokolova, Edward M Schaeffer, Eric J Small, Celestia S Higano. J Natl Compr Canc Netw 2019
33
12

Results of multigene panel testing in familial cancer cases without genetic cause demonstrated by single gene testing.
Mev Dominguez-Valentin, Sigve Nakken, Hélène Tubeuf, Daniel Vodak, Per Olaf Ekstrøm, Anke M Nissen, Monika Morak, Elke Holinski-Feder, Arild Holth, Gabriel Capella,[...]. Sci Rep 2019
6
16

Genetic Counseling and Testing in a Community Setting: Quality, Access, and Efficiency.
Stephanie A Cohen, Angela Bradbury, Vida Henderson, Kent Hoskins, Erica Bednar, Banu K Arun. Am Soc Clin Oncol Educ Book 2019
22
12


The current state of cancer genetic counseling access and availability.
Sara Knapke, Joy Larsen Haidle, Rebecca Nagy, Sara Pirzadeh-Miller. Genet Med 2016
9
12

Hereditary diffuse gastric cancer: updated clinical guidelines with an emphasis on germline CDH1 mutation carriers.
Rachel S van der Post, Ingrid P Vogelaar, Fátima Carneiro, Parry Guilford, David Huntsman, Nicoline Hoogerbrugge, Carlos Caldas, Karen E Chelcun Schreiber, Richard H Hardwick, Margreet G E M Ausems,[...]. J Med Genet 2015
289
12

The CHEK2 I157T variant and breast cancer susceptibility: a systematic review and meta-analysis.
Chuan Liu, Ying Wang, Qing-Shui Wang, Ya-Jie Wang. Asian Pac J Cancer Prev 2012
33
12


Clinical Actionability of Multigene Panel Testing for Hereditary Breast and Ovarian Cancer Risk Assessment.
Andrea Desmond, Allison W Kurian, Michele Gabree, Meredith A Mills, Michael J Anderson, Yuya Kobayashi, Nora Horick, Shan Yang, Kristen M Shannon, Nadine Tung,[...]. JAMA Oncol 2015
204
12

The CHEK2 I157T variant and colorectal cancer susceptibility: a systematic review and meta-analysis.
Chuan Liu, Qing-Shui Wang, Ya-Jie Wang. Asian Pac J Cancer Prev 2012
21
12

Projecting the Supply and Demand for Certified Genetic Counselors: a Workforce Study.
Jennifer M Hoskovec, R L Bennett, M E Carey, J E DaVanzo, M Dougherty, S E Hahn, B S LeRoy, S O'Neal, J G Richardson, C A Wicklund. J Genet Couns 2018
122
12

Modes of delivery of genetic testing services and the uptake of cancer risk management strategies in BRCA1 and BRCA2 carriers.
T Pal, J-H Lee, A Besharat, Z Thompson, A N A Monteiro, C Phelan, J M Lancaster, K Metcalfe, T A Sellers, S Vadaparampil,[...]. Clin Genet 2014
24
12

Clinically guided genetic screening in a large cohort of italian patients with pheochromocytomas and/or functional or nonfunctional paragangliomas.
Massimo Mannelli, Maurizio Castellano, Francesca Schiavi, Sebastiano Filetti, Mara Giacchè, Luigi Mori, Viviana Pignataro, Gianpaolo Bernini, Valentino Giachè, Alessandra Bacca,[...]. J Clin Endocrinol Metab 2009
196
12

Streamlining genetic testing for women with ovarian cancer in a Northern California health care system.
C Bethan Powell, Cecile Laurent, Giuseppe Ciaravino, Christine Garcia, Liz Han, Elizabeth Hoodfar, Audrey Karlea, Christine Kobelka, Jaimie Lee, Ramey D Littell,[...]. Gynecol Oncol 2020
4
25

1
100

Performance of ACMG-AMP Variant-Interpretation Guidelines among Nine Laboratories in the Clinical Sequencing Exploratory Research Consortium.
Laura M Amendola, Gail P Jarvik, Michael C Leo, Heather M McLaughlin, Yassmine Akkari, Michelle D Amaral, Jonathan S Berg, Sawona Biswas, Kevin M Bowling, Laura K Conlin,[...]. Am J Hum Genet 2016
77
12

Spectrum of mutations in BRCA1, BRCA2, CHEK2, and TP53 in families at high risk of breast cancer.
Tom Walsh, Silvia Casadei, Kathryn Hale Coats, Elizabeth Swisher, Sunday M Stray, Jake Higgins, Kevin C Roach, Jessica Mandell, Ming K Lee, Sona Ciernikova,[...]. JAMA 2006
437
12

Detection of inherited mutations for breast and ovarian cancer using genomic capture and massively parallel sequencing.
Tom Walsh, Ming K Lee, Silvia Casadei, Anne M Thornton, Sunday M Stray, Christopher Pennil, Alex S Nord, Jessica B Mandell, Elizabeth M Swisher, Mary-Claire King. Proc Natl Acad Sci U S A 2010
328
12

Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma.
Samuel A Wells, Sylvia L Asa, Henning Dralle, Rossella Elisei, Douglas B Evans, Robert F Gagel, Nancy Lee, Andreas Machens, Jeffrey F Moley, Furio Pacini,[...]. Thyroid 2015
820
12

Risk of Prostate Cancer Associated With Familial and Hereditary Cancer Syndromes.
Jennifer L Beebe-Dimmer, Ashley L Kapron, Alison M Fraser, Ken R Smith, Kathleen A Cooney. J Clin Oncol 2020
10
12

Analysis of hereditary cancer syndromes by using a panel of genes: novel and multiple pathogenic mutations.
Georgios N Tsaousis, Eirini Papadopoulou, Angela Apessos, Konstantinos Agiannitopoulos, Georgia Pepe, Stavroula Kampouri, Nikolaos Diamantopoulos, Theofanis Floros, Rodoniki Iosifidou, Ourania Katopodi,[...]. BMC Cancer 2019
25
12

Candidate genetic modifiers for breast and ovarian cancer risk in BRCA1 and BRCA2 mutation carriers.
Paolo Peterlongo, Jenny Chang-Claude, Kirsten B Moysich, Anja Rudolph, Rita K Schmutzler, Jacques Simard, Penny Soucy, Rosalind A Eeles, Douglas F Easton, Ute Hamann,[...]. Cancer Epidemiol Biomarkers Prev 2015
15
12



Multigene expression profile testing in breast cancer: is there a role for family physicians?
M A O'Brien, J C Carroll, D P Manca, B Miedema, P A Groome, T Makuwaza, J Easley, N Sopcak, L Jiang, K Decker,[...]. Curr Oncol 2017
4
25

Cancer risks in first-degree relatives of CHEK2 mutation carriers: effects of mutation type and cancer site in proband.
J Gronwald, C Cybulski, W Piesiak, J Suchy, T Huzarski, T Byrski, B Gorski, T Debniak, M Szwiec, D Wokolowczyk,[...]. Br J Cancer 2009
24
12

Exome sequencing explained: a practical guide to its clinical application.
Eleanor G Seaby, Reuben J Pengelly, Sarah Ennis. Brief Funct Genomics 2016
28
12


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.